Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0115741
DC FieldValue
dc.titleClonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines
dc.contributor.authorSullivan C.B.
dc.contributor.authorDiggle M.A.
dc.contributor.authorDavies R.L.
dc.contributor.authorClarke S.C.
dc.date.accessioned2019-11-07T05:03:19Z
dc.date.available2019-11-07T05:03:19Z
dc.date.issued2015
dc.identifier.citationSullivan C.B., Diggle M.A., Davies R.L., Clarke S.C. (2015). Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines. PLoS ONE 10 (1) : e115741. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0115741
dc.identifier.issn19326203
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/161751
dc.description.abstractMeningococcal disease remains a public health burden in the UK and elsewhere. Invasive Neisseria meningitidis, isolated in Scotland between 1972 and 1998, were characterised retrospectively to examine the serogroup and clonal structure of the circulating population. 2607 isolates causing invasive disease were available for serogroup and MLST analysis whilst 2517 were available for multilocus sequence typing (MLST) analysis only. Serogroup distribution changed from year to year but serogroups B and C were dominant throughout. Serogroup B was dominant throughout the 1970s and early 1980s until serogroup C became dominant during the mid-1980s. The increase in serogroup C was not associated with one particular sequence type (ST) but was associated with a number of STs, including ST-8, ST-11, ST-206 and ST-334. This is in contrast to the increase in serogroup C disease seen in the 1990s that was due to expansion of the ST-11 clonal complex. While there was considerable diversity among the isolates (309 different STs among the 2607 isolates), a large proportion of isolates (59.9%) were associated with only 10 STs. These data highlight meningococcal diversity over time and the need for ongoing surveillance during the introduction of new meningococcal vaccines. © 2015 Sullivan et al.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20191101
dc.subjectMeningococcus vaccine
dc.subjectArticle
dc.subjectbacterial genome
dc.subjectbacterium identification
dc.subjectbacterium isolate
dc.subjectclonal variation
dc.subjectcontrolled study
dc.subjecthuman
dc.subjectmolecular cloning
dc.subjectmolecular dynamics
dc.subjectmultilocus sequence typing
dc.subjectNeisseria meningitidis
dc.subjectnonhuman
dc.subjectorganisms by geographical distribution
dc.subjectretrospective study
dc.subjectsequence analysis
dc.subjectserotype
dc.subjectspecies diversity
dc.subjectpH
dc.subjectretracted article
dc.subjectNeisseria meningitidis
dc.subjectHydrogen-Ion Concentration
dc.typeArticle
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.description.doi10.1371/journal.pone.0115741
dc.description.sourcetitlePLoS ONE
dc.description.volume10
dc.description.issue1
dc.description.pagee115741
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0115741.pdf599.11 kBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons